← Back to Search

Cialis + Flomax for Kidney Stones

Phase 4
Waitlist Available
Led By Jaime Landman, MD
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up this will be assessed immediately post-op as well as 3 months post-op.
Awards & highlights

Study Summary

This trial is testing whether using an alpha blocker or a phosphodiesterase inhibitor, alone or in combination, can help patients pass a larger ureteral access sheath during ureteroscopy for kidney stones.

Eligible Conditions
  • Kidney Stones

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~this will be assessed immediately post-op as well as 3 months post-op.
This trial's timeline: 3 weeks for screening, Varies for treatment, and this will be assessed immediately post-op as well as 3 months post-op. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Passage of 16F Access Sheath
Secondary outcome measures
Adverse events
Complications
Injury
+1 more

Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: Flomax + PlaceboActive Control1 Intervention
Patients will be prescribed Flomax 0.4Mg Capsule and given a bottle of placebo. They will be instructed to take 1 of each pill for the seven days prior to their surgery.
Group II: Cialis + PlaceboActive Control1 Intervention
Patients will be prescribed Cialis 5Mg tablet and given a bottle of placebo. They will be instructed to take 1 of each pill for the seven days prior to their surgery.
Group III: Cialis + FlomaxActive Control1 Intervention
Patients will be prescribed .4mg of Flomax and 5mg of Cialis. They will be instructed to take 1 of each pill for the seven days prior to their surgery.
Group IV: Placebo + PlaceboPlacebo Group1 Intervention
Given 2 bottles of placebo. They will be instructed to take 1 of each pill for the seven days prior to their surgery.

Find a Location

Who is running the clinical trial?

University of California, IrvineLead Sponsor
544 Previous Clinical Trials
1,922,823 Total Patients Enrolled
2 Trials studying Kidney Stones
3,315 Patients Enrolled for Kidney Stones
Jaime Landman, MDPrincipal InvestigatorUC Irvin Health
7 Previous Clinical Trials
800 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~28 spots leftby May 2025